Survivin Expression by Metastatic Melanoma Predicts Poor Disease Outcome in Patients Receiving Adjuvant Polyvalent Vaccine

International Journal of Cancer - United States
doi 10.1002/ijc.21267
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

CD8+ T Cell Responses in Metastatic Melanoma Patients Receiving an Adenovirally Antigen Engineered Dendritic Cell Vaccine +/- IFN-α

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

High Expression of lncRNA PVT1 Independently Predicts Poor Overall Survival in Patients With Primary Uveal Melanoma

PLoS ONE
Multidisciplinary
2017English

Increased P16 and P53 Protein Expression Predicts Poor Prognosis in Mucosal Melanoma

Oncotarget
Oncology
2017English

High Filamin-C Expression Predicts Enhanced Invasiveness and Poor Outcome in Glioblastoma Multiforme

British Journal of Cancer
Cancer ResearchOncology
2019English

Chemokine Receptor CCR7 Expression Predicts Poor Outcome in Uveal Melanoma and Relates to Liver Metastasis Whereas Expression of CXCR4 Is Not of Clinical Relevance

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2013English

Low P27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

Clinical Cancer Research
Cancer ResearchOncology
2009English

PDCD5 Expression Predicts a Favorable Outcome in Patients With Hepatocellular Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2013English

P38 Predicts Depression and Poor Outcome in Esophageal Cancer

Oncology Letters
Cancer ResearchOncology
2017English

PTEN Loss of Expression Predicts Cetuximab Efficacy in Metastatic Colorectal Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy